Literature DB >> 7087485

Primary tumors of the small bowel: a clinicopathological study of 58 cases.

S Gupta, S Gupta.   

Abstract

Various reviews documenting the rarity, diagnostic problems, and poor survival statistics prompted this retrospective clinicopathological study of 58 cases of primary small bowel tumors, periampullary and mesenteric tumors excluded, over a 14-year period between 1966 and 1979 inclusive. Of these cases 36 were male and 22 were female, ranging in age from 13 to 65 years. Initially, the symptoms were vague and ill defined. Prominent clinical features were: intermittent abdominal pain (6+%), loss of weight (62%), abdominal lump (53%), and chronic bleeding (7%). Routine barium meal examination and laboratory investigations were not helpful in preoperative diagnosis. Of these tumors 28 were benign and 30 malignant, with the commonest benign and malignant tumors being leiomyoma and lymphoma, respectively. The commonest site of involvement was the ileum both for benign and malignant lesions. None of the benign tumors was found in the duodenum. All patients with benign tumors, discovered either at laparotomy for intestinal obstruction or during surgical procedures for other diseases, had excision of the tumor through enterotomy or resection of small bowel with end-to-end anastomosis. Of 30 patients with malignant tumors, 12 underwent resection of the growth and end-to-end anastomosis. Of the remaining 18 unresectable cases, 7 had by-pass procedures and 11 had only biopsy. All patients of benign tumors are well without any gastrointestinal symptoms. All the malignant cases, except three cases of adenocarcinoma and two of lymphoma who underwent resection, died within 5 years. The 5-year survival of only 8.6% in malignant tumors indicates the necessity of an early exploratory laparotomy in doubtful cases with vague abdominal symptoms. A bold interventionist approach should improve the otherwise dismal outlook of malignant small bowel tumors.

Entities:  

Mesh:

Year:  1982        PMID: 7087485     DOI: 10.1002/jso.2930200306

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  Tumors of the small intestine with little or no malignant predisposition: a review of the literature and report of 56 cases.

Authors:  W W Olmsted; P R Ros; B M Hjermstad; M J McCarthy; A H Dachman
Journal:  Gastrointest Radiol       Date:  1987

Review 2.  Imaging of primary small intestinal tumours by enteroclysis and CT with pathological correlation.

Authors:  N Gourtsoyiannis; E Makó
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

3.  Polypoid hamartoma of the jejunum.

Authors:  P G Bracke; H R Degryse; G C Goovaerts; Y M Van Maercke; A M De Schepper
Journal:  Gastrointest Radiol       Date:  1991

Review 4.  Malignant small-bowel neoplasms: spectrum of disease on MR imaging.

Authors:  F Crusco; F Pugliese; A Maselli; G Pelliccia; E Mariani; F Farroni; A Giovagnoni
Journal:  Radiol Med       Date:  2010-09-17       Impact factor: 3.469

Review 5.  CT enteroclysis: technique and clinical applications.

Authors:  Sabine Schmidt; Christian Felley; Jean-Yves Meuwly; Pierre Schnyder; Alban Denys
Journal:  Eur Radiol       Date:  2005-10-12       Impact factor: 5.315

6.  Primary duodenal carcinoma.

Authors:  O A Adedeji; C Trescoli-Serrano; M Garcia-Zarco
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

7.  Impact of magnetic resonance in the preoperative staging and the surgical planning for treating small bowel neoplasms.

Authors:  Giuseppe Pappalardo; Gianfranco Gualdi; Aldo Nunziale; Gabriele Masselli; Irene Floriani; Emanuele Casciani
Journal:  Surg Today       Date:  2012-07-29       Impact factor: 2.549

8.  Computed tomographic distinction of submucosal lipoma and adenomatous polyp of the colon.

Authors:  K J Ho; M S Shin; J M Tishler
Journal:  Gastrointest Radiol       Date:  1984

9.  Small bowel tumours: yield of enteroscopy.

Authors:  B S Lewis; A Kornbluth; J D Waye
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.